Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04579549 · ClinicalTrials.gov registry record · NA
Repeat Testing for SARS-CoV-2
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 464
- Enrollment target
NCT04579549 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 464 participants.
The verdict
NCT04579549, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 464 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if high-frequency, rapid turn-around SARS-CoV-2 surveillance testing with this assay is feasible and able to be optimized to enable isolation and follow-up diagnostic testing. This test will be performed at various locations in the Madison, Wisconsin area using a mobile laboratory or standard lab space for processing. Saliva samples can be collected and processed at these locations or participants can self-collect at home and drop their samples off at designated locations for same day processing. Up to 10000 participants will be recruited for this study.
Interventions
- DEVICE Saliva Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 464 participants |
| Start Date | 2020-09-29 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04579549
The ClinicalTrials.gov registry entry for NCT04579549 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 464 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Saliva Assay is the first listed.
NCT04579549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04579549 about?
NCT04579549 is a clinical study titled "Repeat Testing for SARS-CoV-2". The purpose of this research study is to determine if high-frequency, rapid turn-around SARS-CoV-2 surveillance testing with this assay is feasible and able to be optimized to enable isolation and follow-up diagnostic testing. This test will be performed at various locations in the Madison, Wisconsi...
What is the current status of trial NCT04579549?
This trial is currently completed. It is a NA study. The enrollment target is 464 participants. The study started on 2020-09-29. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT04579549?
The interventions under investigation include: Saliva Assay (DEVICE).
Who is sponsoring clinical trial NCT04579549?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.